Table 3 Characteristics of ALS Patients (N = 279) with mortality follow-up by survival status.
NDeceased | Deceased (N = 104) | NSurvived | Survived (N = 175) | |
|---|---|---|---|---|
Age (years), mean (SD) | 104 | 68.9 (10.3) | 175 | 63.9 (10.2) |
Sex | ||||
Male, N (%) | 104 | 56 (53.9) | 175 | 114 (65.1) |
BMI (kg m−2), mean (SD) | 104 | 24.0 (4.2) | 175 | 24.8 (4.0) |
Leptin (ng mL−1), median (Q1, Q3) | 104 | 7.2 (3.5, 13.3) | 173 | 7.3 (3.8, 12.3) |
Adiponectin (µg mL−1), median (Q1, Q3) | 104 | 10.2 (7.5, 15.2) | 175 | 9.2 (5.8, 14.5) |
Hs-CRP (mg L−1), median (Q1, Q3) | 104 | 1.64 (0.70, 3.18) | 175 | 1.17 (0.61, 3.29) |
Diagnostic delay (month), median (Q1, Q3) | 104 | 3.0 (2.0, 6.0) | 175 | 6.0 (3.0, 9.0) |
ALS-FRS, median (Q1, Q3) | 103 | 36 (32, 41) | 175 | 41 (37, 43) |
